Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/122572
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Control of FLIP L expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells |
Autor: | Yerbes, Rosario CSIC ORCID; López-Rivas, Abelardo CSIC ORCID; Reginato, Mauricio J.; Palacios, Carmen CSIC ORCID | Palabras clave: | ERK1/2 c-Myc FLIP(L) TRAIL Apoptosis |
Fecha de publicación: | 22-jun-2012 | Editor: | Nature Publishing Group | Citación: | Cell Death and Differentiation 19: 1908-1916 (2012) | Resumen: | Increased activation of the epidermal growth factor receptor (EGFR) is frequently observed in tumors, and inhibition of the signaling pathways originated in the EGFR normally renders tumor cells more sensitive to apoptotic stimuli. However, we show that inhibition of EGFR signaling in non-transformed breast epithelial cells by EGF deprivation or gefitinib, an inhibitor of EGFR tyrosine kinase, causes the upregulation of the long isoform of caspase-8 inhibitor FLICE-inhibitory protein (FLIP L) and makes these cells more resistant to the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). We demonstrate that the extracellular signal-regulated kinase (ERK)1/2 pathway plays a pivotal role in the regulation of FLIP L levels and sensitivity to TRAIL-induced apoptosis by EGF. Upregulation of FLIP L upon EGF deprivation correlates with a decrease in c-Myc levels and c-Myc knockdown by siRNA induces FLIP L expression. FLIP L upregulation and resistance to TRAIL in EGF-deprived cells are reversed following activation of an estrogen activatable form of c-Myc (c-Myc-ER). Finally, constitutive activation of the ERK1/2 pathway in HER2/ERBB2-transformed cells prevents EGF deprivation-induced FLIP L upregulation and TRAIL resistance. Collectively, our results suggest that a regulated ERK1/2 pathway is crucial to control FLIP L levels and sensitivity to TRAIL in non-transformed cells, and this mechanism may explain the increased sensitivity of tumor cells to TRAIL, in which the ERK1/2 pathway is frequently deregulated. © 2012 Macmillan Publishers Limited All rights reserved. | Versión del editor: | http://dx.doi.org/10.1038/cdd.2012.78 | URI: | http://hdl.handle.net/10261/122572 | DOI: | 10.1038/cdd.2012.78 | Identificadores: | issn: 1350-9047 e-issn: 1476-5403 |
Aparece en las colecciones: | (CABIMER) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
5
checked on 18-abr-2024
SCOPUSTM
Citations
11
checked on 13-abr-2024
WEB OF SCIENCETM
Citations
12
checked on 22-feb-2024
Page view(s)
263
checked on 18-abr-2024
Download(s)
106
checked on 18-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.